Notas del episodio
Johnson&Johnson, a big pharma company that has been accused of bribed officials and ignoring DEA limits to drive sales of their opioid products. The company's corporate greed and scandalous behavior have led to a massive opioid epidemic, with many people becoming addicts and struggling with withdrawal and detox. The opioid crisis is a complex issue, but it is clear that Johnson&Johnson's actions have contributed to the problem, and their pharma stocks have been impacted as a result. For those struggling with addiction, there is hope for addiction help and recovery, but it will take a concerted effort to address the root causes of the crisis and hold companies like Johnson&Johnson accountable for their role in the opioid crisis and the harm it has caused to drug users and their families. The news of Johnson&Johnson's scandal has sparked outrage and calls for reform, with many demanding that the company take responsibility for its actions and work to prevent future crises. As the situation continues to unfold, it is clear that the opioid epidemic will be a major issue for years to come, and it will take a sustained effort to address the problem and provide support to those affected.